108 related articles for article (PubMed ID: 19487074)
1. Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity.
Lee YM; Lim DY; Cho HJ; Seon MR; Kim JK; Lee BY; Park JH
Cancer Lett; 2009 Nov; 285(2):166-73. PubMed ID: 19487074
[TBL] [Abstract][Full Text] [Related]
2. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
3. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
Hobeika AC; Subramaniam PS; Johnson HM
Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
[TBL] [Abstract][Full Text] [Related]
4. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines.
Wolter F; Clausnitzer A; Akoglu B; Stein J
J Nutr; 2002 Feb; 132(2):298-302. PubMed ID: 11823594
[TBL] [Abstract][Full Text] [Related]
5. trans-10,cis-12 conjugated linoleic acid inhibits the G1-S cell cycle progression in DU145 human prostate carcinoma cells.
Kim EJ; Shin HK; Cho JS; Lee SK; Won MH; Kim JW; Park JH
J Med Food; 2006; 9(3):293-9. PubMed ID: 17004889
[TBL] [Abstract][Full Text] [Related]
6. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
9. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte.
Lee KW; Kim HJ; Lee YS; Park HJ; Choi JW; Ha J; Lee KT
Carcinogenesis; 2007 Sep; 28(9):1928-36. PubMed ID: 17634406
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
11. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
[TBL] [Abstract][Full Text] [Related]
12. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
13. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
[TBL] [Abstract][Full Text] [Related]
18. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
